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Yarrowia lipolyticaIron–sulfur cluster N2 of complex I (proton pumping NADH:quinone oxidoreductase) is the immediate
electron donor to ubiquinone. At a distance of only ∼7 Å in the 49-kDa subunit, a highly conserved tyrosine is
found at the bottom of the previously characterized quinone binding pocket. To get insight into the function
of this residue, we have exchanged it for six different amino acids in complex I from Yarrowia lipolytica.
Mitochondrial membranes from all six mutants contained fully assembled complex I that exhibited very low
dNADH:ubiquinone oxidoreductase activities with n-decylubiquinone. With the most conservative exchange
Y144F, no alteration in the electron paramagnetic resonance spectra of complex I was detectable.
Remarkably, high dNADH:ubiquinone oxidoreductase activities were observed with ubiquinones Q1 and Q2
that were coupled to proton pumping. Apparent Km values for Q1 and Q2 were markedly increased and we
found pronounced resistance to the complex I inhibitors decyl-quinazoline-amine (DQA) and rotenone. We
conclude that Y144 directly binds the head group of ubiquinone, most likely via a hydrogen bond between
the aromatic hydroxyl and the ubiquinone carbonyl. This places the substrate in an ideal distance to its
electron donor iron–sulfur cluster N2 for efﬁcient electron transfer during the catalytic cycle of complex I.cridine; BN-PAGE, blue-native
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Mitochondrial complex I (NADH:ubiquinone oxidoreductase) is a
large membrane protein and the least understood component of the
respiratory chain [1–3]. It is composed of at least 40 subunits with a
total mass of ∼1 MDa [4,5]. In contrast to other respiratory chain
complexes, a complete crystal structure of complex I has not been
solved yet. However, single particle electronmicroscopy revealed that
complex I has an L-shaped overall structure in eukaryotes as well as in
prokaryotes [6–10]. The hydrophobic membrane domain of the
enzyme is embedded in the inner mitochondrial membrane, whereas
the hydrophilic peripheral domain protrudes into the mitochondrialmatrix. Interestingly, the peripheral domain contains all known redox
centers: one non-covalently bound FMN and 8–9 iron–sulfur clusters
[11–14]. In contrast, no redox centers were found in the membrane
domain of complex I [15]. However, this part of the enzyme must
harbor the proton pumping machinery.
The mechanism by which complex I couples the redox reaction of
NADH oxidation and quinone reduction to the translocation of four
protons across the inner mitochondrial membrane [16,17] is still
unknown. However, from recent results it seems that the reduction of
quinone in the peripheral domain induces long range conformational
changes in the membrane domain, which result in proton uptake at
the matrix side of the inner mitochondrial membrane and proton
release into the intermembrane space [3,18,19].
Previously, we suggested that the quinone and inhibitor binding
pocket is located at the interface of the PSST and the 49-kDa subunit
[20,21] (the bovine nomenclature for homologous complex I subunits
will be used throughout). This suggestion was based on several
observations. Firstly, the active site of water-soluble [NiFe] hydro-
genases is located at the interface of the small and large subunits
which are evolutionary related to the PSST and the 49-kDa subunit as
indicated by sequence comparison [22,23]. Secondly, mutagenesis
studies showed that many functionally critical residues are located in
the PSST and the 49-kDa subunit and that mutations which target the
former [NiFe] site conferred resistance towards complex I inhibitors
which act at the quinone binding site [20,24–29]. Thirdly, photo-
afﬁnity labeling studies suggested that the PSST subunit forms part of
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support came from subsequent mutagenesis studies, which identiﬁed
additional functionally important residues in the PSST and 49-kDa
subunit [31–33] and recent photoafﬁnity labeling studies which
showed that the 49-kDa subunit forms part of the inhibitor binding
site of complex I [34]. Finally, the crystal structure of the hydrophilic
domain of complex I from Thermus thermophilus at 3.3 Ångström
resolution [14] conﬁrmed our proposal. The structure revealed the
spatial arrangement of seven central hydrophilic subunits as well as
the locations of all known redox centers of complex I. Seven iron–
sulfur clusters (N1b, N2, N3, N4, N5, N6a und N6b) form an approx-
imately 95 Å long chain of redox centers. This chain starts with iron–
sulfur cluster N3 next to the FMN molecule in the 51-kDa subunit,
continues via the redox centers of the 75-kDa and the TYKY subunits
and ends at iron–sulfur cluster N2 in the PSST subunit adjacent to a
broad cavity at the interface of the PSST and the 49-kDa subunit,
which corresponds to the suggested quinone reduction domain.
Taking advantage of our model organism, the strictly aerobic yeast
Yarrowia lipolytica, we exchanged all amino acid residues located at
the surface of this large cavity. Subsequent structure/function analysis
allowed the identiﬁcation of functional domains [35]. A possible
ubiquinone access path leading from the N-terminal β-sheet of the
49-kDa subunit into the cavity to a tyrosine residing next to iron–
sulfur cluster N2 was identiﬁed. Within the cavity many amino
acid residues were found to be critical for oxidoreductase activity of
complex I. In a more recent study, we used the large array of muta-
tions targeting the quinone binding pocket to identify the binding
sites of different complex I inhibitors [36]. The obtained results sug-
gested that type A, B and C inhibitors [37] indeed bind to the quinone
binding pocket at the interface of the PSST and the 49-kDa subunit and
that the binding sites overlap spatially, as had been deduced from
earlier competition experiments [38].
According to the crystal structure of the hydrophilic domain of
complex I from T. thermophilus [14], Y144 (Y. lipolytica numbering) of
the 49-kDa subunit is located only ∼7 Å away from iron–sulfur cluster
N2, the immediate electron donor to ubiquinone (Fig. 1). This tyrosine
is highly conserved between prokaryotes and eukaryotes (Fig. 2). The
side chain of Y144 seems to deﬁne the border between the PSST
subunit coordinating iron–sulfur cluster N2 and the 49-kDa subunit
forming most of the quinone binding pocket. By systematically
exchanging this tyrosine to aromatic, hydrophilic and hydrophobicFig. 1. Y144 from the 49-kDa subunit is located between iron–sulfur cluster N2 and the qui
purple and beige, respectively. Y144 is highlighted in red. Iron–sulfur cluster N2 is depicted
ﬁgure was prepared with the PyMol software package (version 0.99) using the coordinates
(2FUG). A, Surface representation of the 49-kDa subunit is shown in order to visualize the qu
chain of Y144.amino acids, we show here that this residue is critical for ubiquinone
binding and reduction in complex I.
2. Materials and methods
2.1. Materials
Asolectin (total soy bean extract with 20% lecithin) was purchased
from Avanti Polar Lipids (Alabaster, AL), n-dodecyl-ß-D-maltoside
from Glycon (Luckenwalde, Germany), and octyl-ß-D-glucopyrano-
side from Biomol (Hamburg, Germany). 9-amino-6-chloro-2-meth-
oxyacridine (ACMA) was obtained from Invitrogen/Molecular Probes
(Eugene, OR) and decylubiquinone (DBQ) from Alexis Biochemicals
(Lausen, Switzerland). DQA (2-n-decyl-quinazolin-4-yl-amine, SAN
549) was from AgrEvo (Frankfurt, Germany). Carbonyl-cyanide-p-
triﬂuoromethoxyphenylhydrazone (FCCP) and the ionophore valino-
mycin were from Sigma. ACMA, DBQ, Q1, Q2, DQA, roteonone, and the
ionophores were dissolved in dimethylsulfoxide.
2.2. Site-directed mutagenesis
Site-directed mutagenesis, preparation of mitochondrial mem-
branes, determination of protein concentration, and structural image
preparations were performed as described in [35].
2.3. Analytical methods
Measurement of NADH:HAR and dNADH:DBQ oxidoreductase
activities was performed as described [35]. Inhibitor insensitive
activities were determined in the presence of 27 µM DQA. Apparent
Km and Vmax values for DBQ, Q1 and Q2 weremeasured as described for
dNADH:DBQ oxidoreductase activity [35] except that the concentra-
tions of DBQ, Q1 or Q2 were adjusted to the respective ranges and that
DQA was omitted. A DQA insensitive rate could not be determined
because the concentrations needed to completely block complex I
would have been too high for the mutant strains (see Results).
Instead, background rates determined in parallel with mitochondrial
membranes of the Δnucm strain were subtracted from the rates
measured with the parental and mutant strains in the absence of
inhibitor. Since the Δnucm strain does not contain complex I, these
background rates that were in the same range as the inhibitornone binding pocket. The PSST, the 49-kDa and the TYKY subunits are colored in cyan,
as spheres. Numbers give center-to-center distances between atoms in Ångström. The
from the crystal structure of the hydrophilic domain of complex I from T. thermophilus
inone binding pocket. B, Cartoon representation of the 49-kDa subunit showing the side
Fig. 2. Sequence alignment of the 49-kDa subunit harboring the highly conserved Y144. NCBI sequences of Y. lipolytica (CAG78336), Neurospora crassa (CAA38368), Bos taurus
(P17694), Homo sapiens (AAC27453), P. denitriﬁcans (P29916), T. thermophilus (AAA97941) and E. coli (CAA48363) were aligned by the multiple sequence alignment program
ClustalW. Invariant (*), highly (:) and weakly similar (.) positions are labeled.
Table 1
Effects of point mutations of Y144 in the 49-kDa subunit on complex I content, activity
and iron–sulfur cluster N2 EPR signal in mitochondrial membranes from Y. lipolytica.
Strain Complex I
contenta
Complex I
activityb
dNADH oxidase
activityc
N2 EPR signal
(see EPR spectra below)
% % %
Parental 100±3 100±5 100 Reference
Y144F 110±2 15±2 5 Not altered
Y144W 129±2 11±4 b5 N2 signal slightly shifted
Y144I 59±1 12±1 b5 No N2 signal
Y144H 86±2 5±3 b5 N2 signal slightly shifted
Y144S 94±4 13±1 n.d. Reduced N2 signal
Y144R 58±1 8±1 n.d. No N2 signal
n.d., not determined.
a 100% of complex I content corresponds to 1.25 µmol min−1 mg−1 NADH:HAR
oxidoreductase activity determined for the parental strain. Mean values±SEM are
given.
b Speciﬁc complex I activity was determined as dNADH:DBQ oxidoreductase activity
from which the insensitive rate in the presence of 27 µM DQA of the parental strain
(0.06 µmol min−1 mg−1) was subtracted. The activities were normalized to complex I
content and the activity of the parental strain (0.46 µmol min−1 mg−1) was set as
100%. Mean values±SEM are given.
c In order to determine speciﬁc dNADH oxidase activities by probing the entire
respiratory chain via endogenous Q9 the insensitive rate in the presence of 27 µM DQA
of the parental strain (0.04 µmol min−1 mg−1) was subtracted for each strain. The
activities were normalized to complex I content and the activity of the parental strain
(0.12 µmol min−1 mg−1) was set as 100%.
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ﬁtted to the Michaelis–Menten equation using the Enzﬁtter software
package, and the value for substrate concentration [S] was corrected
as described earlier [39]. To obtain comparable maximal activities
for different strains, the Vmax values were normalized to complex I
content of the respective mitochondrial membrane preparations.
I50 values were determined in the presence of 180 µM Q1 as the
concentration needed to inhibit 50% of the initial rate minus the
insensitive rate that was determined at the maximal concentration
of the respective inhibitor. In the case of DQA and rotenone, the
insensitive rate for the parental strain was also used for membranes
from the mutant strains, because maximal inhibition was not reached
due to pronounced inhibitor resistance.
Samples for EPR were reduced by NADH. It is not necessary to use
dNADH for reduction of membrane samples because NDH-2 does not
contain any paramagnetic cofactors which might contribute to the
EPR spectrum. EPR spectroscopy was performed as described in [35].
All other parameters are given in the ﬁgure legends. BN-PAGE was
performed as described in [40].
2.4. Preparation of complex I and proteoliposomes
Complex I was puriﬁed as described previously [41] with two
minormodiﬁcations: (i) after ultracentrifugation the supernatant was
adjusted to 55 mM imidazole and pH 7.4. (ii) the imidazole con-
centration for equilibration and washing of the Ni-NTA fast ﬂow
Sepharose column was reduced from 65 mM to 55 mM.
Complex I proteoliposomeswere prepared from puriﬁed complex I
as described in [42] with minor modiﬁcations as detailed in [43].
Proton pumping by complex I proteoliposomes was determined by
ACMA quench as described previously [42].
3. Results
3.1. Complex I assembly but no dNADH:DBQ oxidoreductase activity in
Y144 mutants
In order to gain insight into the function of Y144 we changed it to
phenylalanine and tryptophan retaining the aromatic character, to the
hydrophobic isoleucine and to the hydrophilic amino acids histidine,
serine and arginine. Mutant Y144H has been described before [20],
however it was characterized in a different genetic background at the
time and was therefore generated and analyzed again here.
Mitochondrial membranes were isolated from the tyrosine
mutants and complex I content was estimated as NADH:HAR oxido-
reductase activity (Table 1). In mutants Y144I and Y144R complex I
content was moderately reduced to ∼60% and in mutant Y144W itwas increased to ∼130%. Within experimental error, mutants Y144F,
Y144H and Y144S exhibited unchanged amounts of complex I. These
results were conﬁrmed by BN-PAGE followed by complex I in-gel
activity staining (data not shown). Apparently, Y144was not essential
for complex I assembly and/or stability, but spacious hydrophobic or
hydrophilic residues were less well tolerated than aromatic residues
at this position.
Measurement of speciﬁc dNADH:DBQ oxidoreductase activities
revealed that all mutations resulted in a drastic reduction in complex I
activity (Table 1). Notably, this was also true for Y144F, the mutant
where just the aromatic hydroxyl group had been removed. Even
concentrations of DBQ up to 140 µM corresponding to ∼10 times the
apparent Km of the parental strain or variation of the pH value or
addition of varying concentrations of different anions that could have
potentially served as proton-carriers in proteins (chloride, bromide,
iodide, azide, formate or acetate) did not stimulate complex I activity
in mitochondrial membranes from mutant Y144F (data not shown).
Remarkably, when we measured the dNADH oxidase activity to probe
for the activity of the entire respiratory chain via the endogenous
substrate Q9, we also found very low activities (Table 1).
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Since Y144 is only ∼7 Å away from iron–sulfur cluster N2 (Fig. 1),
mutations of this tyrosine could have abolished complex I activity by
interfering with this cluster. To test this, EPR spectra of mitochondrial
membranes from Y144 mutant strains were recorded. As shown in
Fig. 3 and summarized in Table 1, the EPR signals of iron–sulfur cluster
N2 in mutants Y144F, Y144W and Y144H were, if at all, only slightly
changed when compared to the parental strain. Mutant Y144S
displayed clear changes in a region where mainly the gz and the gxy
signals of iron–sulfur cluster N2 contributed to the spectrum. In
mutants Y144I and Y144R no cluster N2 EPR signals were visible.
Mutant Y144W revealed some shift of signals to lower ﬁeld in the gxy
region of cluster N2. This was also visible in the N2 spectrum derived
from puriﬁed enzyme (Fig. 4), but the gz signal seemed unchanged.
Mutant Y144H had been shown previously to display a slight shift
in the signal of iron–sulfur cluster N2 [20]. Since small changes in the
EPR signals of iron–sulfur cluster N2 cannot be detected in mito-
chondrial membranes, complex I from mutants Y144F and Y144W
was puriﬁed for a more detailed EPR analysis. However, in standard
EPR spectra recorded at 12 K no changes were evident in theFig. 3. EPR signals of iron–sulfur cluster N2 in Y144mutants. EPR spectra were recorded
from mitochondrial membranes at 12 K and 5 mW microwave power. Field regions
where signals originated predominantly from cluster N2 are highlighted in gray. Y144F,
Y144W and Y144H showed, if at all, onlyminor changes when compared to the parental
strain. In Y144S signiﬁcant changes in N2 signals were observed, whereas in Y144I and
Y144R no iron–sulfur cluster N2 derived signals were detected. The prominent signal at
3340 G in all spectra was due to oxidized iron–sulfur cluster S3 of complex II. For
sample preparation, mitochondrial membranes (25 mg protein per ml) were reduced
by 2 mM NADH.
Fig. 4. EPR spectra of iron–sulfur cluster N2 in complex I from mutants Y144F and
Y144W. 25 K minus 40 K difference EPR spectra from puriﬁed complex I of mutants
Y144F and Y144W were compared to a highly concentrated complex I reference.
Vertical lines indicate minima andmaxima from the gz and the gxy signals of iron–sulfur
cluster N2. In contrast to mutant Y144F, a small shift of the gxy signal of iron–sulfur
cluster N2 was evident for mutant Y144W. Original 40 K and 25 K EPR spectra were
recorded at 2 mW microwave power from samples reduced with 5 mM NADH.signatures of iron–sulfur cluster N2 in puriﬁed complex I frommutant
Y144F (data not shown). By subtracting EPR spectra recorded at 40 K
that show only signals of the slow relaxing 2Fe–2S cluster N1 from
spectra recorded at 25 K that show signals from N1 and the 4Fe–4S
cluster N2, essentially pure spectra of iron–sulfur cluster N2 were
obtained (Fig. 4). In these spectra the gxy signal of iron–sulfur cluster
N2 was shifted slightly towards lower ﬁeld in mutant Y144W. In
mutant Y144F however, the EPR signature of cluster N2 was
unchanged, indicating that the environment of iron–sulfur cluster
N2 was not affected signiﬁcantly by removing the hydroxyl group of
Y144.
Overall, the effects of the tyrosine mutations on the EPR signal of
iron–sulfur cluster N2 are in excellent agreement with the close
proximity of this residue to cluster N2. Consistent with their desta-
bilizing effect on complex I, mutations Y144I and Y144R completely
abolished the EPR signal of cluster N2 (Fig. 3; Table 1). In contrast,
mutation Y144F did not interfere with iron–sulfur cluster N2 at all,
indicating that the near complete loss of complex I activity in this
mutant was not due to changes in the environment of iron–sulfur
cluster N2.
3.3. dNADH:Q1 oxidoreductase activities and apparent Km values
It has been reported that the reactivity of ubiquinone derivatives
with complex I depends on the properties of their isoprenoid or
aliphatic side chains [44–48]. Therefore, we also tested our mutants
with themore hydrophilic Q1 carrying one isoprenoidmoiety as a side
chain that is also frequently used as electron acceptor in routine
assays of complex I.
We assayed the activity with Q1 as electron acceptor in mutants
Y144F, Y144W and Y144H. In these mutants the environment of iron–
sulfur cluster N2 was, if at all, only slightly altered (Fig. 4; [20]). In
contrast to the measurements with DBQ, we observed considerable
dNADH:Q1 oxidoreductase activities and could thus determine
Michaelis–Menten parameters for this substrate. As shown in
Table 2, mutant Y144F reached more than 70% and mutant Y144W
reached more than 90% of the maximal dNADH:Q1 oxidoreductase
activity of the parental strain. Mutant Y144H reached 48% of parental
Table 2
Apparent Km and Vmax values for Y144 mutants with Q1 as electron acceptor.
Strain Apparent Km for Q1 Vmax for Q1 normalized to CI contenta
µM µmol min−1 mg−1 %
Parental 9±1 0.29±0.01 100±3
Y144F 54±7 0.21±0.01 72±3
Y144W 130±30 0.27±0.06 93±21
Y144H 180±60 0.14±0.04 48±14
Mean values±SEM.
a The Vmax values were normalized to complex I content in mitochondrial
membranes that was estimated as NADH:HAR oxidoreductase activity.
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any activity was detectable for these mutants with DBQ (Table 1). The
apparent Km value for Q1 was six times higher in mutants Y144F and
even about fourteen times higher when Y144 was exchanged to the
bulkier tryptophan in mutant Y144W. With mutant Y144H the
apparent Km value could hardly be determined, but was at the order
of 20 times the value of the parental strain.
3.4. dNADH:Q2 oxidoreductase activities and apparent Km values
We then measured dNADH:Q2 oxidoreductase activities in mito-
chondrial membranes from mutants Y144F and Y144W and deter-
mined the Michaelis–Menten parameters for Q2. As shown in Table 3,
the normalized Vmax values for both mutants were similar to the
values determined for Q1 and in mutant Y144W this parameter was
essentially identical to the parental strain. However, the apparent Km
values had only doubled relative to the parental strain. Thus, in
comparison to the values determined for Q1, the changes in the
apparent Km value for Q2 were much less pronounced. We conclude
that in mitochondrial membranes from the Y144 mutants Q2 was an
even better substrate than Q1.
In summary, the dNADH:ubiquinone oxidoreductase activities and
apparent Km values in mitochondrial membranes from the Y144
mutants strongly depended on the structure of the side chain of the
ubiquinone derivative used.
3.5. Proton pumping by complex I from mutant Y144F
Since mutant Y144F displayed high oxidoreductase activities with
Q1 and Q2 as substrates, we next tested whether this redox reaction
was linked to vectorial proton pumping by complex I and thus,
whether these ubiquinone derivatives were reduced at the physio-
logical site. For this purpose, puriﬁed complex I from mutant Y144F
was reconstituted into proteoliposomes and proton pumping was
monitored as quench in ACMA ﬂuorescence. As indicated by the
ﬂuorescence quench upon addition of NADH (Fig. 5), complex I from
mutant Y144F exhibited proton pumping activities with all three
ubiquinone derivatives. The ACMA traces quite well reﬂected the
differences in electron transfer activities observed with the different
substrates that were quite similar in membranes and for the enzyme
reconstituted into proteoliposomes. While the decay in ﬂuorescence
for complex I from Y144F was very slow with DBQ, the traces with Q1Table 3
Apparent Km and Vmax values for Y144 mutants with Q2 as electron acceptor.
Strain Apparent Km for Q2 Vmax with Q2 normalized to CI contenta
µM µmol min−1 mg−1 %
Parental 7±1 0.31±0.01 100±3
Y144F 11±2 0.23±0.03 74±10
Y144W 14±2 0.32±0.03 103±10
Mean values±SEM.
a The Vmax values were normalized to complex I content in mitochondrial
membranes that was estimated as NADH:HAR oxidoreductase activity.and Q2 were comparable for parental and mutant complex I. In
contrast to parental complex I however, the ACMA quench was
reverted only partially upon addition of 10 µM of the complex I
inhibitor DQA. This reﬂected the pronounced resistance of mutant
Y144F for this inhibitor (see below). Complete restoration of the
ACMA ﬂuorescence to the level prior to the addition of NADH was
achieved by addition of the protonophor FCCP.
The ﬁnding that all dNADH:ubiquinone oxidoreductase activities
of the tyrosine mutant were linked to proton pumping indicated that
these activities reﬂected the physiological reaction. Moreover, these
results highlight the tight coupling between redox reaction and
vectorial proton pumping in complex I.
3.6. Inhibitor resistance
Since the dNADH:Q1 oxidoreductase activity of complex I in
mutant Y144F was coupled to proton translocation and thus Q1
reduction clearly occurred at the physiological site, we testedwhether
exchanges of Y144 affected inhibitor binding at the quinone binding
pocket. We determined I50 values for DQA, rotenone and C12E8 as
representatives of all three classes of complex I inhibitors. As shown in
Table 4, removal of the hydroxyl group of Y144 by the Y144F exchange
was sufﬁcient to induce an almost 1000-fold resistance towards DQA
and a 3.7 fold resistance towards rotenone. Even higher resistance
was observed when the tyrosine was exchanged for the larger
tryptophan. The dramatic increase of the I50 values for DQA in both
mutants suggested that Y144 is a critical component of the binding
site for this inhibitor. In contrast, rotenone binding seemed to be less
directly affected by the mutations. Remarkably, both mutants
exhibited a slight hypersensitivity for C12E8, as has been observed
for a number of other mutants in the ubiquinone binding pocket [36].
Note however that the rate that could not be inhibited even at very
high concentrations of C12E8 was markedly higher in both mutants
(not shown). Overall, these results lend further support to the idea
that complex I contains a large quinone binding pocket with distinct
but overlapping binding sites for the three types of inhibitors [38].
4. Discussion
We show that the conserved Y144 of the 49-kDa subunit of
complex I is directly involved in the binding of the substrate
ubiquinone. This is consistent with its central position within the
quinone binding pocket only ∼7 Å away from iron–sulfur cluster N2,
the immediate electron donor to ubiquinone ([14,35]; Fig. 1).
Exchanging this tyrosine with a series of six different amino acids
did not prevent complex I assembly; however, in all cases the dNADH:
DBQ oxidoreductase activity of complex I was drastically reduced. This
was also true for complex I from mutant Y144F in which only the
hydroxyl group of Y144 was missing. While in all other mutants
changes in the EPR signature of the nearby iron–sulfur cluster N2
ranged from a slight shift to complete loss of the signal, no effect was
seen in mutant Y144F. This excluded structural changes in the
environment or the loss of the electron donor for ubiquinone as
reasons for the decreased catalytic activity. Rather, it seemed that a
critical binding interaction was lost in the mutant, with a hydrogen
bond between the tyrosine-hydroxyl and a carbonyl of the ubiquinone
head group being the most obvious option.
When we tested the activities with the short chain isoprenoid
derivatives Q1 and Q2, complex I from mutants Y144F and Y144W
exhibited high ubiquinone reductase activities that for Y144W
reached the level of the parental strain (Tables 2 and 3). However,
signiﬁcant changes in the apparent Km that were much more
pronounced in the case of Q1 suggested that also binding of these
ubiquinone derivatives was affected. We conclude that the isoprene
moieties, most likely through hydrophobic and π–π interactions
of their double bond, contributed signiﬁcantly to substrate binding,
Fig. 5. Proton pumping by proteoliposomes containing complex I from the parental strain andmutant Y144F. In the presence of 60 µMDBQ, Q1 or Q2, the addition of NADH resulted in
the buildup of a proton gradient across the membrane of the proteoliposomes that was monitored as a quench of ACMA ﬂuorescence. Addition of the complex I inhibitor DQA
reverted this quench, however in the case ofmutant Y144F only addition of the protonophore FCCP returned the signal back to the level prior to NADH addition. The line shapes of the
ACMA ﬂuorescence signal for the mutant with Q1 and Q2 were comparable to those of the parental strain, indicating that this mutation did not interfere with proton pumping. Even
with DBQ as substrate some ACMA ﬂuorescence quench was observed. Proteoliposomes containing ∼20 µg of complex I were added to 2 ml buffer (20 mMK+/Mops pH 7.2, 80 mM
KCl, 0.5 µM valinomycin) in a stirred cuvette. H+-translocation was monitored as ﬂuorescence change of ACMA that was added to a ﬁnal concentration of 0.5 µM. Measurements
were performed in a Shimadzu RF-5001 ﬂuorimeter at an excitation wavelength of 430 nm and an emission wavelength of 475 nm (band pass 5 nm each, integration time 1 s) at
30 °C. Arrows indicate time points for the additions of 60 µM ubiquinone derivative, 100 µM NADH, 10 µM DQA and 1 µM FCCP.
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Km value for Q1 in the case of mutant Y144W may indicate that in
addition to the loss of the hydrogen bond, the bulky tryptophan may
have distorted the binding site, weakening the binding interaction
with the isoprenoid moiety. The reduced effect of the two mutations
on the apparent Km for Q2 suggests that also the second isoprene-
residue made binding interactions with complex I, thereby further
reducing the effect of abolishing the hydrogen bond with Y144.
One may infer that an increasing number of binding interactions
should also result in a corresponding decrease of the Km values for the
different ubiquinone derivatives in the parental strain. However, this
correlation is difﬁcult to assess because only apparent Km values could
be measured that do not take into account the different hydropho-
bicity of the substrates that are likely to affect the effective con-Table 4
I50 values for DQA, rotenone and C12E8 determined in mitochondrial membranes from
tyrosine mutants in the presence of Q1.
Strain I50
DQA Rotenone C12E8
nM nM nM
Parental 10 950 3000
Y144F 9500 3500 1500
Y144W 14,000 7000 1500centration at the binding site. If one considers the membrane/water
logP values [46] of 4.7 for DBQ, 2.9 for Q1 and 4.0 for Q2, it becomes
clear that also this parameter cannot be applied in a straightforward
way. Consistent with the proposed difference in the number of
binding interactions, an apparent Km of 15 µM for DBQ and of 9 µM for
Q1 indeed seems to suggest a much weaker binding of DBQ if one
takes into account that the difference in the partition coefﬁcient is
almost two orders of magnitude. However, this argument does not
hold if one compares Q1 and Q2, because the higher logP and the
assumed additional binding interaction for Q2 together would have
suggested amuch larger difference in the apparent Km values thanwas
actually observed. This may suggest that the exact position and
interactions of the ubiquinone side chains may depend on the length
and steric properties of the side chain. Indeed, it has been known
for a long time that short chain ubiquinones exhibit some degree
of substrate inhibition in complex I from bovine heart [46,48] and
P. denitriﬁcans [49,50] suggesting a different mode of binding as
compared to long chain ubiquinones, the physiological substrates of
complex I. Moreover, speciﬁc binding of the quinone isoprenyl side
chain by complex I was demonstrated earlier [51]. Notably, we found
for the three mutants still containing essentially normal amounts of
iron–sulfur cluster N2 that the dNADH oxidase activities employing
the physiological substrate Q9 were even lower than the dNADH:DBQ
oxidoreductase activities (Table 1). It is tempting to speculate that this
could also suggest different binding modes of the ﬁrst two isoprenoid
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action with the quinone binding pocket of complex I near Y144 for
the longer variants. Because it is technically difﬁcult to add larger
amounts of the extremely hydrophobic endogenous substrate Q9 to
mitochondrial membranes, we could not test whether higher con-
centrations would have increased the activity. Therefore, the question
whether a distorted orientation of the isoprenoid double bonds or a
speciﬁc folding of the side chain of the long chain ubiquinone within
the binding pocket are responsible for the low activities of the mutant
complexes with the physiological substrate has to remain unan-
swered at this point.
In summary, our results clearly show that the aromatic hydroxyl
group of tyrosine 144 is directly involved in binding the substrate, but
not required for efﬁcient electron transfer. Understanding the detailed
interaction of the ubiquinone derivatives with complex I will require
further studies.
Remarkably, mutations Y144F and Y144W also resulted in drastic
resistance to DQA, suggesting that this inhibitor also binds directly to
this tyrosine qualifying it as a true quinone analog. The inhibitory
efﬁciencies of rotenone and C12E8 were only moderately altered,
suggesting that the binding of these compounds was affected only
indirectly by the mutations. This is consistent with the idea of a large
binding pocket with distinct but overlapping inhibitor binding sites
[36,38].
Basedon structural studieswith theperipheral armof T. thermophilus
complex I, it has been proposed recently that Y144 (Y87 in
T. thermophilus) of the 49-kDa subunit may act as a proton-donor and
may be involved in ubiquinone protonation or a possible direct proton
pumping mechanism [52]. This seems highly unlikely based on our
ﬁnding that complex I from mutant Y144F, after reconstitution into
proteoliposomes, pumped protons efﬁciently when Q1 or Q2 were used
as substrates. Our results clearly demonstrate that redox linked proton
pumping was functional in complex I from mutant Y144F and that the
hydroxyl group of Y144 was not required for substrate protonation or
proton pumping.
We conclude that Y144 directly binds the head group of ubi-
quinone most likely via a hydrogen bond between the aromatic
hydroxyl and the quinone carbonyl. This places the substrate in an
ideal distance to its electron donor iron–sulfur cluster N2 for efﬁcient
electron transfer during the catalytic cycle of complex I.
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